ShayanShirazianMD

Physician

Overview of Dr. Shirazian

Dr. Shayan Shirazian is a nephrologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian/Hudson Valley Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, and NewYork-Presbyterian/Allen Hospital. He received his medical degree from The Warren Alpert Medical School of Brown University and has been in practice 12 years. Dr. Shirazian accepts several types of health insurance, listed below. He is one of 171 doctors at New York-Presbyterian Hospital and one of 62 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Nephrology. He has more than 40 publications and over 500 citings.

Office
622 W 168th St
New York, NY 10032
Book by Phone+1(928) 440-8940

Fax+1 212-305-6692

Education & Training

New York Presbyterian Hospital (Cornell Campus)Fellowship, Nephrology, 2008 - 2010
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2005 - 2008
The Warren Alpert Medical School of Brown UniversityClass of 2005

Certifications & Licensure

FL State Medical License 2022 - Present
NY State Medical License 2007 - 2026
CT State Medical License 2023 - 2025
NJ State Medical License 2022 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011

Clinical Trials

Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol Start of enrollment: 2012 Nov 01
Terminated
Phase 4
WEMR With Clinical Decision Support for All Wounds Start of enrollment: 2013 Apr 01
Withdrawn
WEMR With Clinical Decision Support for Diabetic Foot Ulcers Start of enrollment: 2013 Apr 01
Withdrawn
Risk of Chronic Kidney Disease Progression Start of enrollment: 2013 May 01
Completed
A Study of Ferric Citrate to Improve Inflammation and Lipid Levels Start of enrollment: 2015 Jul 01
Terminated
Phase 4
Improving Outcomes for Hemodialysis Patients Start of enrollment: 2018 May 01
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

69 citations
CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease
Laura H. Mariani, Andrew S. Bomback, Pietro A. Canetta, Michael F. Flessner, Margaret E. Helmuth
American Journal of Kidney Diseases. 2019-02-01
97 citations
A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant
Naoka Murakami, Patrick M. Mulvaney, Melissa J. Danesh, Ala Abudayyeh, Adi Diab
Kidney International. 2021-07-01
211 citations
Clinical features and outcomes of immune checkpoint inhibitor-associated AKI: A multicenter study
Frank B. Cortazar, Zoe A. Kibbelaar, Ilya G. Glezerman, Ala Abudayyeh, Omar Mamlouk
Journal of the American Society of Nephrology. 2020-01-02

Press Mentions

A 61-Year-Old Man with Membranoproliferative GlomerulonephritisDecember 1st, 2017

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Cofinity PPO
Coventry Carelink Health Plans PPO
Empire BCBS HMO
Empire BCBS PPO
First Health PPO
GHI PPO
Great West PPO
HealthAmerica HealthAssurance PPO
HIP of New York - Select PPO
Humana ChoiceCare Network PPO
Humana/ChoiceCare+ Network PPO
MagnaCare PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
Sagamore Health Plus
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment